Reported July 30: Annexon Inks $200M Credit Facility Agreement With Oxford Finance
Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10 million people worldwide, today
Annexon got a $200 million loan from a bank called Oxford Finance, which gives the company money to keep working on medicines. This shows the bank believes in Annexon's plans, so watch if the company hits its research goals on time.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.